Literature DB >> 166925

Herpes simplex virus infection in guinea pigs: an animal model for studying latent and recurrent herpes simplex virus infection.

M Scriba.   

Abstract

Footpad infection of guinea pigs with herpes simplex virus led to an acute local inflammatory reaction, followed by a persistent latent infection of lumbosacral dorsal root ganglia. Spontaneous reactivation of the latent virus occurred, leading to recurrent lesions at the site of the initial infection. Clinical observations and virological studies during the acute latent and recurrent infection are reported.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 166925      PMCID: PMC415261          DOI: 10.1128/iai.12.1.162-165.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  5 in total

1.  Recovery of herpes-simplex virus from human trigeminal ganglions.

Authors:  J R Baringer; P Swoveland
Journal:  N Engl J Med       Date:  1973-03-29       Impact factor: 91.245

2.  Latent herpes simplex virus from trigeminal ganglia of rabbits with recurrent eye infection.

Authors:  J G Stevens; A B Nesburn; M L Cook
Journal:  Nat New Biol       Date:  1972-02-16

3.  Recovery of herpes simplex virus from human sacral ganglions.

Authors:  J R Baringer
Journal:  N Engl J Med       Date:  1974-10-17       Impact factor: 91.245

4.  Latent herpes simplex virus in spinal ganglia of mice.

Authors:  J G Stevens; M L Cook
Journal:  Science       Date:  1971-08-27       Impact factor: 47.728

5.  Herpesvirus hominis: isolation from human trigeminal ganglion.

Authors:  F O Bastian; A S Rabson; C L Yee; T S Tralka
Journal:  Science       Date:  1972-10-20       Impact factor: 47.728

  5 in total
  26 in total

1.  Animal studies on the efficacy of an inactivated herpes simplex virus vaccine against recurrent herpes infection.

Authors:  M Scriba
Journal:  Infection       Date:  1978       Impact factor: 3.553

2.  Reliable in vivo model for latent herpes simplex virus reactivation with peripheral virus shedding.

Authors:  A B Nesburn; M T Green; M Radnoti; B Walker
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

3.  Protective effect of an oral infection with herpes simplex virus type 1 against subsequent genital infection with herpes simplex virus type 2.

Authors:  B Sturn; K E Schneweis
Journal:  Med Microbiol Immunol       Date:  1978-07-04       Impact factor: 3.402

4.  Pathogenetic mechansims of recurrent herpes simplex virus infections.

Authors:  R J Klein
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

5.  Recurrent genital Herpes simplex virus (HSV) infection of guinea pigs.

Authors:  M Scriba
Journal:  Med Microbiol Immunol       Date:  1976-12-01       Impact factor: 3.402

6.  Evaluation of a novel, anti-herpes simplex virus compound, acyclovir elaidate (P-4010), in the female guinea pig model of genital herpes.

Authors:  R Jennings; T L Smith; F Myhren; J Phillips; M L Sandvold
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

7.  Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs.

Authors:  L R Stanberry; S Kit; M G Myers
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

8.  Pathogenesis of latent herpes simplex virus infection of the trigeminal ganglion in guinea pigs: effects of age, passive immunization, and hydrocortisone.

Authors:  R B Tenser; G D Hsiung
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

9.  Protection of guinea pigs against primary and recurrent genital herpes infections by immunization with live heterologous or homologous Herpes simplex virus: implications for a herpes virus vaccine.

Authors:  M Scriba
Journal:  Med Microbiol Immunol       Date:  1978-11-17       Impact factor: 3.402

10.  Immunity to herpes simplex virus type 2: cell-mediated immunity in latently infected guinea pigs.

Authors:  A D Donnenberg; E Chaikof; L Aurelian
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.